u 74389f has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, P; Cook, D; Findlay, M; Vollrath, B | 1 |
| Altavilla, D; Arlotta, M; Campo, GM; Caputi, AP; Quartarone, C; Saitta, A; Sardella, A; Squadrito, F; Squadrito, G; Urna, G | 1 |
2 other study(ies) available for u 74389f and Muscle Contraction
| Article | Year |
|---|---|
Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle.
Topics: Animals; Antioxidants; Calcium; Cell Line; Cell Survival; Chelating Agents; Chromans; Deferoxamine; Disease Models, Animal; Dogs; Female; Free Radical Scavengers; Hydrogen Peroxide; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Iron; Ischemic Attack, Transient; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oxyhemoglobins; Piperazines; Pregnatrienes; Subarachnoid Hemorrhage | 1995 |
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
Topics: Alanine Transaminase; Animals; Antioxidants; Aorta, Thoracic; Bilirubin; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Endotoxemia; Heart Rate; In Vitro Techniques; Lipopolysaccharides; Liver; Male; Muscle Contraction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Phenylephrine; Pregnatrienes; Rats; Rats, Sprague-Dawley; Survival Rate; Vasoconstrictor Agents | 1999 |